{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:47:47Z","timestamp":1791830867354,"version":"4.3.4"},"reference-count":123,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.ejphar.2019.172762","type":"journal-article","created":{"date-parts":[[2019,10,26]],"date-time":"2019-10-26T01:39:06Z","timestamp":1572053946000},"page":"172762","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":115,"special_numbering":"C","title":["Aspirin and its pleiotropic application"],"prefix":"10.1016","volume":"866","author":[{"given":"Jolanta","family":"Hybiak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izabela","family":"Broniarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Kiryczy\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura.D.","family":"Los","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Rosik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Machaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"S\u0142awi\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kornelia","family":"Jankowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u017cbieta","family":"Urasi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2019.172762_bib1","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.eururo.2017.01.044","article-title":"Regular aspirin use and the risk of lethal prostate cancer in the Physicians' health study","volume":"72","author":"Downer","year":"2017","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejphar.2019.172762_bib2","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1056\/NEJMoa010178","article-title":"Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease","volume":"345","author":"in 't Veld","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2019.172762_bib3","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/sj.bjc.6604880","article-title":"Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis","volume":"100","author":"Abnet","year":"2009","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.ejphar.2019.172762_bib39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1474-4422(07)70293-4","article-title":"Aspirin in Alzheimer\u2019s disease (AD2000): a randomised open-label trial","volume":"7","author":"AD2000 Collaborative Group","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejphar.2019.172762_bib40","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jalz.2014.03.009","article-title":"Follow-up evaluation of cognitive function in the randomized Alzheimer\u2019s disease anti-inflammatory prevention trial and its follow-up study","volume":"11","author":"ADAPT-FS Research Group","year":"2015","journal-title":"Alzheimer\u2019s Dementia\u202f: J. Alzheimers Assoc."},{"key":"10.1016\/j.ejphar.2019.172762_bib4","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1001\/jama.289.21.2819","article-title":"Effects of rofecoxib or naproxen vs placebo on Alzheimer disease ProgressionA randomized controlled trial","volume":"289","author":"Aisen","year":"2003","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.ejphar.2019.172762_bib5","series-title":"Bahrain through the Ages","author":"Al-Khalifa","year":"1993"},{"key":"10.1016\/j.ejphar.2019.172762_bib6","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S1470-2045(12)70112-2","article-title":"Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials","volume":"13","author":"Algra","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ejphar.2019.172762_bib7","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1160\/TH04-02-0127","article-title":"Aspirin and coronary artery disease","volume":"92","author":"Andrew","year":"2004","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ejphar.2019.172762_bib8","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2340\/0001555565230234","article-title":"Treatment of necrobiosis lipoidica with low-dose acetylsalicylic acid. A randomized double-blind trial","volume":"65","author":"Beck HI","year":"1985","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.ejphar.2019.172762_bib9","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1741-7015-11-74","article-title":"Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness","volume":"11","author":"Berk","year":"2013","journal-title":"BMC Med."},{"key":"10.1016\/j.ejphar.2019.172762_bib10","doi-asserted-by":"crossref","first-page":"836","DOI":"10.7326\/M16-0577","article-title":"Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S. Preventive Services task Force recommendation statement aspirin use for the primary prevention of CVD and CRC","volume":"164","author":"Bibbins-Domingo","year":"2016","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejphar.2019.172762_bib11","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1093\/annonc\/mds113","article-title":"Aspirin and cancer risk: a quantitative review to 2011","volume":"23","author":"Bosetti","year":"2012","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ejphar.2019.172762_bib12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s40256-014-0100-5","article-title":"A systematic review of aspirin in primary prevention: is it time for a new approach?","volume":"15","author":"Brotons","year":"2015","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"10.1016\/j.ejphar.2019.172762_bib13","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1056\/NEJMoa0801297","article-title":"Effect of aspirin or resistant starch on colorectal neoplasia in the lynch syndrome","volume":"359","author":"Burn","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2019.172762_bib14","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1359\/jbmr.2003.18.10.1795","article-title":"Association between bone mineral density and the use of nonsteroidal anti-inflammatory drugs and aspirin: impact of cyclooxygenase selectivity","volume":"18","author":"Carbone","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ejphar.2019.172762_bib15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1053\/j.gastro.2007.09.035","article-title":"Aspirin dose and duration of use and risk of colorectal cancer in men","volume":"134","author":"Chan","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2019.172762_bib16","doi-asserted-by":"crossref","first-page":"110","DOI":"10.15171\/jnp.2017.19","article-title":"The effect of aspirin on kidney allograft outcomes; a short review to current studies","volume":"6","author":"Cheungpasitporn","year":"2017","journal-title":"J. Nephropathol."},{"key":"10.1016\/j.ejphar.2019.172762_bib17","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/jnci\/djn485","article-title":"Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials","volume":"101","author":"Cole","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ejphar.2019.172762_bib18","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1476-5381.1960.tb00288.x","article-title":"Analgesic antipyretic drugs as antagonists of bradykinin","volume":"15","author":"Collier","year":"1960","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"10.1016\/j.ejphar.2019.172762_bib19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.7326\/0003-4819-159-2-201307160-00002","article-title":"Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial","volume":"159","author":"Cook","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejphar.2019.172762_bib20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10897-013-9629-8","article-title":"Aspirin use is associated with lower prostate cancer risk in male carriers of BRCA mutations","volume":"23","author":"Cossack","year":"2014","journal-title":"J. Genet. Couns."},{"key":"10.1016\/j.ejphar.2019.172762_bib21","first-page":"27","article-title":"Aspirin and colorectal cancer prevention and treatment: is it for everyone?","volume":"12","author":"Coyle","year":"2016","journal-title":"Curr. Colorectal Cancer Rep."},{"key":"10.1016\/j.ejphar.2019.172762_bib22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jds.2016.03.009","article-title":"Lower dosage of aspirin promotes cell growth and osteogenic differentiation in murine bone marrow stromal cells","volume":"11","author":"Du","year":"2016","journal-title":"J. Dent. Sci."},{"key":"10.1016\/j.ejphar.2019.172762_bib23","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41420-019-0170-x","article-title":"Low-dose aspirin protective effects are correlated with deregulation of HNF factor expression in the preeclamptic placentas from mice and humans","volume":"5","author":"Ducat","year":"2019","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.ejphar.2019.172762_bib24","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/bmj.322.7282.329","article-title":"Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review","volume":"322","author":"Duley","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.ejphar.2019.172762_bib25","article-title":"Antiplatelet agents for preventing pre\u2010eclampsia and its complications","volume":"2","author":"Duley","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejphar.2019.172762_bib26","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1706441","article-title":"Randomized trial of verubecestat for mild-to-moderate Alzheimer's disease","volume":"378","author":"Egan","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2019.172762_bib27","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1812840","article-title":"Randomized trial of verubecestat for prodromal Alzheimer's disease","volume":"380","author":"Egan","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2019.172762_bib28","doi-asserted-by":"crossref","first-page":"e89S","DOI":"10.1378\/chest.11-2293","article-title":"Antiplatelet drugs: antithrombotic therapy and prevention of thrombosis, ninth ed.: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"vol. 141","author":"Eikelboom","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.ejphar.2019.172762_bib29","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-013636","article-title":"AspiriN to Inhibit SEPSIS (ANTISEPSIS) randomised controlled trial protocol","volume":"7","author":"Eisen","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.ejphar.2019.172762_bib30","first-page":"1","article-title":"Does low dose aspirin prescribed for risk of early onset preeclampsia reduce the prevalence of preterm prelabor rupture of membranes?","author":"El-Achi","year":"2019","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.ejphar.2019.172762_bib31","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008481","article-title":"Aspirin and the risk of colorectal cancer in relation to the expression of 15-hydroxyprostaglandin dehydrogenase (HPGD)","volume":"6","author":"Fink","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejphar.2019.172762_bib32","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/ana.20774","article-title":"Coxibs and Alzheimer's disease: should they stay or should they go?","volume":"59","author":"Firuzi","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejphar.2019.172762_bib33","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1529\/biophysj.105.077784","article-title":"A computational protocol for the integration of the monotopic protein prostaglandin H2 synthase into a phospholipid bilayer","volume":"91","author":"Fowler","year":"2006","journal-title":"Biophys. J."},{"key":"10.1016\/j.ejphar.2019.172762_bib34","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/bjc.2014.264","article-title":"Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study","volume":"111","author":"Fraser","year":"2014","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.ejphar.2019.172762_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170775","article-title":"The influence of BRAF and KRAS mutation status on the association between aspirin use and survival after colon cancer diagnosis","volume":"12","author":"Frouws","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2019.172762_bib36","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1734-1140(10)70262-0","article-title":"COX-2 as a target for cancer chemotherapy","volume":"62","author":"Ghosh","year":"2010","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejphar.2019.172762_bib37","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/S0140-6736(49)91829-2","article-title":"Aspirin in the treatment of vascular diseases","volume":"2","author":"Gibson","year":"1949","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2019.172762_bib38","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/irv.12421","article-title":"Antiviral activity of aspirin against RNA viruses of the respiratory tract-an in vitro study","volume":"11","author":"Glatthaar-Saalm\u00fcller","year":"2017","journal-title":"Influenza Other Resp. Viruses"},{"key":"10.1016\/j.ejphar.2019.172762_bib41","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/01.AOG.0000437382.03963.88","article-title":"Hypertension in pregnancy: executive summary","volume":"122","year":"2013","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ejphar.2019.172762_bib42","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1200\/JCO.2016.70.7547","article-title":"Aspirin use and colorectal cancer survival according to tumor CD274 (programmed cell death 1 ligand 1) expression status","volume":"35","author":"Hamada","year":"2017","journal-title":"J. Clin. Oncol. : Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2019.172762_bib43","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1073\/pnas.72.8.2994","article-title":"Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides","volume":"72","author":"Hamberg","year":"1975","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2019.172762_bib44","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0968-4328(02)00029-X","article-title":"In vitro fibrillogenesis of the amyloid \u03b21\u201342 peptide: cholesterol potentiation and aspirin inhibition","volume":"33","author":"Harris","year":"2002","journal-title":"Micron"},{"key":"10.1016\/j.ejphar.2019.172762_bib45","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1007\/s00432-019-02932-0","article-title":"Safety and efficacy of aspirin for primary prevention of cancer: a meta-analysis of randomized controlled trials","volume":"145","author":"Haykal","year":"2019","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2019.172762_bib46","doi-asserted-by":"crossref","first-page":"5575","DOI":"10.1016\/S0021-9258(17)33098-3","article-title":"Purification of the cyclooxygenase that forms prostaglandins. Demonstration of two forms of iron in the holoenzyme","volume":"251","author":"Hemler","year":"1976","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2019.172762_bib47","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-4362.1989.tb02465.x","article-title":"Healing of necrobiotic ulcers with antiplatelet therapy correlation with plasma thromboxane levels","volume":"28","author":"Heng","year":"1989","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.ejphar.2019.172762_bib48","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1158\/0008-5472.CAN-16-2400","article-title":"Aspirin suppresses growth in PI3K-mutant breast cancer by activating AMPK and inhibiting mTORC1 signaling","volume":"77","author":"Henry","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2019.172762_bib49","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1067\/mob.2000.106757","article-title":"Preeclampsia prevention: lessons from the low-dose aspirin therapy trials","volume":"183","author":"Heyborne","year":"2000","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ejphar.2019.172762_bib50","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.neuropharm.2005.07.004","article-title":"Non-steroidal anti-inflammatory drugs have anti-amyloidogenic effects for Alzheimer's \u03b2-amyloid fibrils in vitro","volume":"49","author":"Hirohata","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2019.172762_bib51","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ijdevneu.2005.11.001","article-title":"Neuroinflammation and regeneration in the early stages of Alzheimer's disease pathology","volume":"24","author":"Hoozemans","year":"2006","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.ejphar.2019.172762_bib52","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1464-5491.2001.00452.x","article-title":"Squamous cell carcinoma developing in necrobiosis lipoidica","volume":"18","author":"Imtiaz","year":"2001","journal-title":"Diabet. Med."},{"key":"10.1016\/j.ejphar.2019.172762_bib53","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/jnci\/djk132","article-title":"A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence","volume":"99","author":"Jacobs","year":"2007","journal-title":"JNCI: J. Natl. Cancer Inst."},{"key":"10.1016\/j.ejphar.2019.172762_bib54","series-title":"Aspirin: the Remarkable Story of a Wonder Drug","author":"Jeffreys","year":"2004"},{"key":"10.1016\/j.ejphar.2019.172762_bib55","first-page":"496","article-title":"Preeclampsia","author":"Jos\u00e9 Geraldo","year":"2017","journal-title":"Rev. Bras. Ginecol. Obstet."},{"key":"10.1016\/j.ejphar.2019.172762_bib57","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-019-1135-y","article-title":"Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study","volume":"21","author":"Kehm","year":"2019","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.ejphar.2019.172762_bib58","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1053\/j.gastro.2017.12.001","article-title":"Regular use of aspirin or non-aspirin nonsteroidal anti-inflammatory drugs is not associated with risk of incident pancreatic cancer in two large cohort studies","volume":"154","author":"Khalaf","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2019.172762_bib59","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1056\/NEJMe1903193","article-title":"Lowering of amyloid-beta by \u03b2-secretase inhibitors \u2014 some informative failures","volume":"380","author":"Knopman","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2019.172762_bib60","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nature14034","article-title":"Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance","volume":"517","author":"Kurtova","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2019.172762_bib61","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/0002-9343(91)90160-Y","article-title":"Erythromelalgia: review of clinical characteristics and pathophysiology","volume":"91","author":"Kurzrock","year":"1991","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejphar.2019.172762_bib62","first-page":"342","article-title":"The treatment of acute rheumatism by salicin","volume":"4","author":"Lagan","year":"1876","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2019.172762_bib63","doi-asserted-by":"crossref","first-page":"13207","DOI":"10.1016\/S0021-9258(17)36820-5","article-title":"Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin","volume":"269","author":"Lecomte","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2019.172762_bib64","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/CCM.0000000000003630","article-title":"Treatment with acetylsalicylic acid reverses endotoxin tolerance in humans in vivo: a randomized placebo-controlled study","volume":"47","author":"Leijte","year":"2019","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ejphar.2019.172762_bib65","doi-asserted-by":"crossref","first-page":"16830","DOI":"10.1073\/pnas.1406997111","article-title":"Differential impairment of aspirin-dependent platelet cyclooxygenase acetylation by nonsteroidal antiinflammatory drugs","volume":"111","author":"Li","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejphar.2019.172762_bib66","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1056\/NEJMoa1207756","article-title":"Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival","volume":"367","author":"Liao","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2019.172762_bib67","article-title":"Aspirin: the story of a wonder drug","volume":"329","author":"Lichterman","year":"2004","journal-title":"BMJ Br. Med. J. (Clin. Res. Ed.)"},{"key":"10.1016\/j.ejphar.2019.172762_bib68","doi-asserted-by":"crossref","first-page":"18928","DOI":"10.1002\/jcp.28533","article-title":"Low-dose aspirin reduces hypoxia-induced sFlt1 release via the JNK\/AP-1 pathway in human trophoblast and endothelial cells","volume":"234","author":"Lin","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejphar.2019.172762_bib69","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1161\/01.CIR.91.7.2080","article-title":"Effects of aspirin on platelet-neutrophil interactions","volume":"91","author":"L\u00f3pez-Farr\u00e9","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2019.172762_bib70","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cct.2015.11.014","article-title":"Slowing the progression of age-related hearing loss: rationale and study design of the ASPIRIN in HEARING, retinal vessels imaging and neurocognition in older generations (ASPREE-HEARING) trial","volume":"46","author":"Lowthian","year":"2016","journal-title":"Contemp. Clin. Trials"},{"key":"10.1016\/j.ejphar.2019.172762_bib71","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1212\/01.wnl.0000260269.93245.d2","article-title":"Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial","volume":"68","author":"Lyketsos","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2019.172762_bib72","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1349-7006.2012.02200.x","article-title":"Thromboxane A(2) receptor signaling facilitates tumor colonization through P-selectin-mediated interaction of tumor cells with platelets and endothelial cells","volume":"103","author":"Matsui","year":"2012","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ejphar.2019.172762_bib73","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1073\/pnas.96.1.272","article-title":"Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2","volume":"96","author":"McAdam","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejphar.2019.172762_bib74","unstructured":"Medicine, U.S.N.L.o., ClinicalTrials.gov."},{"key":"10.1016\/j.ejphar.2019.172762_bib75","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejogrb.2003.12.030","article-title":"Pathophysiology of preeclampsia: links with implantation disorders","volume":"115","author":"Merviel","year":"2004","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.ejphar.2019.172762_bib76","doi-asserted-by":"crossref","first-page":"466","DOI":"10.7326\/0003-4819-102-4-466","article-title":"Erythromelalgia caused by platelet-mediated arteriolar inflammation and thrombosis in thrombocythemia","volume":"102","author":"Michiels","year":"1985","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejphar.2019.172762_bib77","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1056\/NEJM197905173002006","article-title":"Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls","volume":"300","author":"Moncada","year":"1979","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2019.172762_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2018.10.008","article-title":"The first 3500\u202fyears of aspirin history from its roots \u2013 a concise summary","volume":"113","author":"Montinari","year":"2019","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172762_bib79","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/jid.2014.531","article-title":"Aspirin and nonsteroidal anti-inflammatory drugs can prevent cutaneous squamous cell carcinoma: a systematic review and meta-analysis","volume":"135","author":"Muranushi","year":"2015","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.ejphar.2019.172762_bib80","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/jama.2015.1815","article-title":"Association of aspirin and NSAID use with risk of colorectal cancer according to genetic Variants NSAID-colorectal cancer association by genetic variant NSAID-colorectal cancer association by genetic variant","volume":"313","author":"Nan","year":"2015","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.ejphar.2019.172762_bib81","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1006\/bbrc.1999.1840","article-title":"Thromboxane A(2) regulation of endothelial cell migration, angiogenesis, and tumor metastasis","volume":"267","author":"Nie","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2019.172762_bib82","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1001\/jama.2013.6599","article-title":"Aspirin use and risk of colorectal cancer according to BRAF mutation status aspirin use and colorectal cancer BRAF mutation status","volume":"309","author":"Nishihara","year":"2013","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.ejphar.2019.172762_bib83","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/QAI.0b013e31828a292c","article-title":"Aspirin attenuates platelet activation and immune activation in HIV-1-infected subjects on antiretroviral therapy: a pilot study","volume":"63","author":"O'Brien","year":"2013","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.ejphar.2019.172762_bib84","article-title":"Targeting thrombogenicity and inflammation in chronic HIV infection","volume":"5","author":"O'Brien","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejphar.2019.172762_bib85","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1080\/14737175.2018.1531706","article-title":"BACE inhibitors in clinical development for the treatment of Alzheimer's disease","volume":"18","author":"Panza","year":"2018","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.ejphar.2019.172762_bib86","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1172\/JCI110576","article-title":"Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects","volume":"69","author":"Patrignani","year":"1982","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2019.172762_bib87","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJM199405053301808","article-title":"Aspirin as an antiplatelet drug","volume":"330","author":"Patrono","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2019.172762_bib88","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jacc.2015.05.012","article-title":"The multifaceted clinical readouts of platelet inhibition by low-dose aspirin","volume":"66","author":"Patrono","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2019.172762_bib89","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.jacc.2017.08.037","article-title":"Antiplatelet agents for the treatment and prevention of coronary atherothrombosis","volume":"70","author":"Patrono","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2019.172762_bib90","doi-asserted-by":"crossref","first-page":"e13133","DOI":"10.1111\/ctr.13133","article-title":"Early aspirin initiation following heart transplantation is associated with reduced risk of allograft vasculopathy during long-term follow-up","volume":"31","author":"Peled","year":"2017","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.ejphar.2019.172762_bib91","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/223029a0","article-title":"Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs","volume":"223","author":"Piper","year":"1969","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2019.172762_bib92","first-page":"63","article-title":"Gene transfer of thromboxane A(2) synthase and prostaglandin I(2) synthase antithetically altered tumor angiogenesis and tumor growth","volume":"62","author":"Pradono","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2019.172762_bib93","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0002-9343(83)90529-6","article-title":"Aspirin, prostaglandins, and peripheral gangrene","volume":"74","author":"Preston","year":"1983","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejphar.2019.172762_bib94","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jaad.2013.05.034","article-title":"Update on necrobiosis lipoidica: a review of etiology, diagnosis, and treatment options","volume":"69","author":"Reid","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejphar.2019.172762_bib95","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1021\/jm068021c","article-title":"Drug discovery. A history by Walter sneader. John Wiley & sons ltd., west sussex, England. 2005. x + 468 pp. 17 \u00d7 24.5 cm. ISBN 0471899801 (paperback). $65.00","volume":"49","author":"Roche","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2019.172762_bib96","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1073\/pnas.72.8.3073","article-title":"Acetylation of prostaglandin synthase by aspirin","volume":"72","author":"Roth","year":"1975","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejphar.2019.172762_bib97","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(10)61543-7","article-title":"Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials","volume":"376","author":"Rothwell","year":"2010","journal-title":"The Lancet"},{"key":"10.1016\/j.ejphar.2019.172762_bib98","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(10)62110-1","article-title":"Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials","volume":"377","author":"Rothwell","year":"2011","journal-title":"The Lancet"},{"key":"10.1016\/j.ejphar.2019.172762_bib99","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/S0140-6736(12)60209-8","article-title":"Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials","volume":"379","author":"Rothwell","year":"2012","journal-title":"The Lancet"},{"key":"10.1016\/j.ejphar.2019.172762_bib100","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(18)31133-4","article-title":"Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials","volume":"392","author":"Rothwell","year":"2018","journal-title":"The Lancet"},{"key":"10.1016\/j.ejphar.2019.172762_bib101","series-title":"Acetylsalicylic Acid","author":"Schr\u00f6r","year":"2016"},{"key":"10.1016\/j.ejphar.2019.172762_bib102","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/ptr.5377","article-title":"Efficacy and safety of white willow bark (salix alba) extracts","volume":"29","author":"Shara","year":"2015","journal-title":"Phytother Res."},{"key":"10.1016\/j.ejphar.2019.172762_bib103","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jamaoncol.2018.4154","article-title":"Association between aspirin use and risk of hepatocellular CarcinomaAssociation between aspirin use and risk of hepatocellular CarcinomaAssociation between aspirin use and risk of hepatocellular carcinoma","volume":"4","author":"Simon","year":"2018","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ejphar.2019.172762_bib104","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1136\/bmj.321.7276.1591","article-title":"The discovery of aspirin: a reappraisal","volume":"321","author":"Sneader","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.ejphar.2019.172762_bib105","series-title":"Drug Discovery: a History","author":"Sneader","year":"2005"},{"key":"10.1016\/j.ejphar.2019.172762_bib106","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4292\/wjgpt.v5.i1.40","article-title":"Aspirin, cyclooxygenase inhibition and colorectal cancer","volume":"5","author":"Sostres","year":"2014","journal-title":"World J. Gastrointest. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2019.172762_bib107","doi-asserted-by":"crossref","first-page":"270","DOI":"10.2340\/0001555561270271","article-title":"A randomized double blind comparison of an aspirin dipyridamole combination versus a placebo in the treatment of necrobiosis lipoidica","volume":"61","author":"Statham B","year":"1981","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.ejphar.2019.172762_bib108","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1212\/01.wnl.0000284596.95156.48","article-title":"NSAID use and dementia risk in the Cardiovascular Health Study: role of APOE and NSAID type","volume":"70","author":"Szekely","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2019.172762_bib109","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.prostaglandins.2007.01.007","article-title":"15-hydroxyprostaglandin dehydrogenase (15-PGDH) and lung cancer","volume":"83","author":"Tai","year":"2007","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.ejphar.2019.172762_bib110","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrclinonc.2011.199","article-title":"The role of aspirin in cancer prevention","volume":"9","author":"Thun","year":"2012","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2019.172762_bib111","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neulet.2005.11.066","article-title":"Acetylsalicylic acid decreases tau phosphorylation at serine 422","volume":"396","author":"Tortosa","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2019.172762_bib112","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djt431","article-title":"Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the ovarian cancer association consortium","volume":"106","author":"Trabert","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ejphar.2019.172762_bib113","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10549-016-3729-8","article-title":"Mutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirin","volume":"156","author":"Turturro","year":"2016","journal-title":"Breast Canc. Res. Treat."},{"key":"10.1016\/j.ejphar.2019.172762_bib114","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1182\/blood-2006-01-010645","article-title":"Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions","volume":"109","author":"Undas","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2019.172762_bib115","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/newbio231232a0","article-title":"Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs","volume":"231","author":"Vane","year":"1971","journal-title":"Nat. New Biol."},{"key":"10.1016\/j.ejphar.2019.172762_bib116","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev.pharmtox.38.1.97","article-title":"Cyclooxygenases 1 and 2","volume":"38","author":"Vane","year":"1998","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2019.172762_bib117","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1258\/jrsm.2008.081007","article-title":"The willow as a Hottentot (Khoikhoi) remedy for rheumatic fever","volume":"101","author":"Volmink","year":"2008","journal-title":"J. R. Soc. Med."},{"key":"10.1016\/j.ejphar.2019.172762_bib118","first-page":"7","article-title":"Assessment of bleeding risk in patients with coronary artery disease on dual antiplatelet therapy","volume":"115","author":"Vries","year":"2015","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ejphar.2019.172762_bib119","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1152\/physiol.00043.2008","article-title":"Preeclampsia: the role of angiogenic factors in its pathogenesis","volume":"24","author":"Wang","year":"2009","journal-title":"Physiology"},{"key":"10.1016\/j.ejphar.2019.172762_bib120","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3233\/JAD-141506","article-title":"Anti-inflammatory drugs and risk of Alzheimer's disease: an updated systematic review and meta-analysis","volume":"44","author":"Wang","year":"2015","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.ejphar.2019.172762_bib121","series-title":"Aspirin for Vascular Dementia","author":"Williams","year":"2000"},{"key":"10.1016\/j.ejphar.2019.172762_bib122","series-title":"Murder, Magic and Medicine, by John Mann. Pp 232","first-page":"112","author":"Wood","year":"1993"},{"key":"10.1016\/j.ejphar.2019.172762_bib123","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2014.0317","article-title":"From plant extract to molecular panacea: a commentary on Stone (1763) 'An account of the success of the bark of the willow in the cure of the agues","volume":"370","author":"Wood","year":"2015","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.ejphar.2019.172762_bib124","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.cell.2015.08.015","article-title":"Cyclooxygenase-dependent tumor growth through evasion of immunity","volume":"162","author":"Zelenay","year":"2015","journal-title":"Cell"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919307149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919307149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:32:28Z","timestamp":1757975548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299919307149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":123,"alternative-id":["S0014299919307149"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.172762","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspirin and its pleiotropic application","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.172762","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"172762"}}